Even when HIV is undetectable, it may remain transmissible via breast milk

Publicly released:
Australia; International; NSW
CC-0. https://www.pexels.com/photo/man-wearing-red-ribbon-3900469/
CC-0. https://www.pexels.com/photo/man-wearing-red-ribbon-3900469/

Argentinian and Australian scientists evaluated HIV remaining in the breast milk of two women with the virus who were on successful long-term treatment and found the risk of HIV transmission via breast milk could not be ruled out, although they did not find any signs of intact or active HIV. The team evaluated HIV DNA in breast milk over the first seven weeks of lactation in one 'exceptional elite controller', who spontaneously managed to control virus levels for nine years, from a woman with HIV receiving antiretroviral therapy whose viral load was undetectable for more than five years, and a woman who did not have HIV. They found HIV DNA remained in the breast milk of both women with HIV, although levels were very low.  In terms of more intact copies of the virus, they found none in the elite controller and just four defective copies in the woman on antiretroviral therapy. Although they were not able to rule out HIV transmission via breast milk, the researchers say the risk is very low, and guidelines should allow new mums with HIV to make informed decisions in conjunction with their doctors about whether to breastfeed.

Media release

From: American College of Physicians

First report of its kind describes HIV reservoir landscape in breast milk

In the first report of its kind, researcher from the University of Buenos Aires evaluated the HIV reservoir in the breast milk cells of two women living with HIV (WLWH) who had been on successful long-term treatment. While the researchers did not find any signs of intact or active HIV that could potentially cause infection in others, the risk for transmission in breast milk could not be entirely ruled out. According to the researchers, studies like this one are increasingly important as infant feeding guidelines for people LWH continue to change. The brief research report is published in Annals of Internal Medicine.

The idea that "Undetectable = Untransmittable" (U=U) means people with HIV who have an undetectable viral load can’t pass on the virus. However, this principle hasn't yet been proven for breastfeeding, as there's still a very small risk of transmission. For many years, guidelines in wealthy countries focused on avoiding any risk, even tiny ones, by discouraging breastfeeding for people with HIV. Recently, guidelines like the Swiss guidelines and those in the U.S. have started to consider the importance of making informed, shared decisions between patients and doctors.

The researchers evaluated free virus and cell-associated HIV DNA in breast milk over the first 7 weeks of lactation from an exceptional elite controller (the “Esperanza” patient) with 9 years of spontaneous viral control, from a WLWH receiving ART (abacavir– lamivudine–dolutegravir) with undetectable viral loads for more than 5 years, and a control patient. Very low levels of cellular HIV DNA (0.08 to 0.74 HIV DNA copies per million cells) were detected in the women with HIV; after analyzing 14 million cells from the elite controller, the researchers detected no HIV provirus by full-length individual proviral sequencing, and in 11 million cells from the woman receiving long-term dolutegravir, they detected only 4 defective HIV copies with large internal deletions. According to the authors, these data are reassuring and support the revised recommendations on infant feeding by PLWH in high resource settings.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research American College of Physicians, Web page The URL will go live after the embargo ends
Editorial / Opinion American College of Physicians, Web page The URL will go live after the embargo ends
Journal/
conference:
Annals of Internal Medicine
Research:Paper
Organisation/s: The Westmead Institute for Medical Research, The University of Sydney, Universidad de Buenos Aires, Argentina
Funder: Dr. Fisher, Ms. Casanova, and Dr. Palmer were supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award UM1AI164560.
Media Contact/s
Contact details are only visible to registered journalists.